Novugen is an innovator in the generics and biosimilars market. Since its inception, it has dived in headfirst into the industry, taking on difficulties and sparking new ideas. In this exclusive interview, Novugen’s CEO Rahil Mahmood explores the strategic moves that has set the stage to launching this Malaysian jewel to the forefront of the pharmaceutical world.